$CBIS The company will begin contacting the chosen individuals to begin trials in the near future. Applicants for additional new treatments are being sought out, and shareholders are encouraged to apply for these initial test studies. These new clinical studies will accept 50 patients each, the company hopes to streamline the clinical studies process to bring the medication to more patients with a full-scale launch soon.
https://finance.yahoo.com/news/cannabis-scien...20336.html
(0)
(0)
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!